Commerzbank Aktiengesellschaft’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.39M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.49M | Buy |
|
|||||
|
2024
Q4 | $963K | Buy |
|
|||||
|
2024
Q3 | $838K | Sell |
|
|||||
|
2024
Q2 | $1.4M | Buy |
|
|||||
|
2024
Q1 | $561K | Buy |
|
|||||
|
2023
Q4 | $378K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $510K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4.89M | Sell |
|
|||||
|
2020
Q1 | $14.8M | Buy |
|
|||||
|
2019
Q4 | $12.7M | Sell |
|
|||||
|
2019
Q3 | $18.1M | Sell |
|
|||||
|
2019
Q2 | $20.3M | Sell |
|
|||||
|
2019
Q1 | $24.1M | Sell |
|
|||||
|
2018
Q4 | $27.4M | Sell |
|
|||||
|
2018
Q3 | $42M | Buy |
|
|||||
|
2018
Q2 | $30.2M | Buy |
|
|||||
|
2018
Q1 | $28.8M | Sell |
|
|||||
|
2017
Q4 | $29.8M | Sell |
|
|||||
|
2017
Q3 | $36.3M | Buy |
|
|||||
|
2017
Q2 | $25.5M | Sell |
|
|||||
|
2017
Q1 | $35.8M | Sell |
|
|||||
|
2016
Q4 | $46.4M | Buy |
|
|||||
|
2016
Q3 | $50M | Sell |
|
|||||
|
2016
Q2 | $85.1K | Buy |
|
|||||
|
2016
Q1 | $60.2M | Sell |
|
|||||
|
2015
Q4 | $155M | Buy |
|
|||||
|
2015
Q3 | $143M | Buy |
|
|||||
|
2015
Q2 | $165M | Sell |
|
|||||
|
2015
Q1 | $158M | Buy |
|
|||||
|
2014
Q4 | $133M | Sell |
|
|||||
|
2014
Q3 | $173M | Buy |
|
|||||
|
2014
Q2 | $98.9M | Buy |
|
|||||
|
2014
Q1 | $70.4M | Buy |
|
|||||
|
2013
Q4 | $78.7M | Sell |
|
|||||
|
2013
Q3 | $113M | Buy |
|
|||||
|
2013
Q2 | $75.5M | Buy |
|